Dimensional Fund Advisors’s 89bio ETNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,606,783
Closed -$23.6M 3265
2025
Q3
$23.6M Buy
1,606,783
+423,560
+36% +$4.32M 0.01% 1903
2025
Q2
$11.6M Buy
1,183,223
+595,237
+101% +$4.93M ﹤0.01% 2220
2025
Q1
$4.28M Buy
587,986
+245,757
+72% +$2.15M ﹤0.01% 2539
2024
Q4
$2.68M Buy
+342,229
New +$2.82M ﹤0.01% 2720
2023
Q4
Sell
-55,488
Closed -$857K 3429
2023
Q3
$857K Sell
55,488
-34,046
-38% -$572K ﹤0.01% 2956
2023
Q2
$1.7M Hold
89,534
﹤0.01% 2822
2023
Q1
$1.36M Buy
89,534
+18,508
+26% +$241K ﹤0.01% 2833
2022
Q4
$904 Hold
71,026
﹤0.01% 2919
2022
Q3
$411K Buy
+71,026
New +$312K ﹤0.01% 3087

Other funds holding ETNB

Dimensional Fund Advisors's ETNB Position: Q4 2025 in Review

Dimensional Fund Advisors sold out of 89bio (ETNB) in Q4 2025, closing a stake of 1,606,783 shares — an estimated $23.6M sold.

Dimensional Fund Advisors first reported a position in ETNB in Q3 2022 and held it in 9 quarters. The position peaked at $23.6M in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Dimensional Fund Advisors reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Dimensional Fund Advisors sold 1,606,783 89bio shares in Q4 2025, an estimated $23.6M.
  • Dimensional Fund Advisors first reported a position in 89bio in Q3 2022 and held it in 9 quarters.
  • Dimensional Fund Advisors's 89bio position peaked at $23.6M in Q3 2025.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Dimensional Fund Advisors's 13F filing for Q4 2025, filed 12 Feb 2026.